Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).
Journal: American journal of hematology
Published: June 25, 2026
Weakened macrophage antibacterial capacity in myelodysplastic syndrome.
Journal: ImmunoHorizons
Published: June 03, 2026
Analysis of CD8 Cytotoxic T-Cells in Patients With Myelodysplastic Neoplasms and T-Cell Large Granulocyte Lymphocytic Leukemia.
Journal: European journal of haematology
Published: March 19, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.
Journal: Blood cancer journal
Published: March 13, 2026
A Phase 1/1b Study of the All-Oral Regimen CC-486 and Venetoclax in Acute Myeloid Leukemia.
Journal: Blood advances
Published: February 20, 2026
siRNA Mediated Genetic Perturbation of Primary Human Leukemia Stem and Progenitor Cells.
Journal: bioRxiv : the preprint server for biology
Published: September 26, 2025
Tolerability and Outcomes With Serial Cycles of 28 Days of Venetoclax in Newly Diagnosed Patients With Acute Myeloid Leukemia.
Journal: American journal of hematology
Published: September 20, 2025
Omacetaxine and azacitidine for untreated patients with myelodysplastic syndromes and excess blasts: a phase I/II clinical trial.
Journal: EClinicalMedicine
Published: May 22, 2025
Known Prognostic Models Fail to Predict Outcomes for Venetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia: A Single-Center Retrospective Analysis.
Journal: American journal of hematology
Published: May 14, 2025
Impact of demographic factors on clinical outcomes of patients with acute myeloid leukemia.
Journal: Haematologica
Published: April 29, 2025
Comparison of treatment-related and de novo CCUS: a retrospective analysis from two centers.
Journal: Leukemia & lymphoma
Published: March 13, 2025
Last Updated: 09/26/2026